Lataa...
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
Endothelin receptor antagonism has emerged as an important therapeutic approach in pulmonary arterial hypertension (PAH). Bench to bedside scientific research has shown that endothelin-1 (ET-1) is overexpressed in several forms of pulmonary vascular disease and may play an important pathogenetic rol...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2605321/ https://ncbi.nlm.nih.gov/pubmed/19183742 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|